Figure 2.
Kaplan‐Meier analysis of overall survival for patients with clear cell metastatic renal cell carcinoma who received first‐line sunitinib since 2010, stratified by IMDC prognostic risk groups. Abbreviations: CI, confidence interval; IMDC, International Metastatic Renal Cell Carcinoma Database Consortium.

Kaplan‐Meier analysis of overall survival for patients with clear cell metastatic renal cell carcinoma who received first‐line sunitinib since 2010, stratified by IMDC prognostic risk groups. Abbreviations: CI, confidence interval; IMDC, International Metastatic Renal Cell Carcinoma Database Consortium.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close